433 related articles for article (PubMed ID: 33526482)
21. Discovery of chebulagic acid and punicalagin as novel allosteric inhibitors of SARS-CoV-2 3CL
Du R; Cooper L; Chen Z; Lee H; Rong L; Cui Q
Antiviral Res; 2021 Jun; 190():105075. PubMed ID: 33872675
[TBL] [Abstract][Full Text] [Related]
22. Discovery and mechanism of action of Thonzonium bromide from an FDA-approved drug library with potent and broad-spectrum inhibitory activity against main proteases of human coronaviruses.
Wang R; Zhai G; Zhu G; Wang M; Gong X; Zhang W; Ge G; Chen H; Chen L
Bioorg Chem; 2023 Jan; 130():106264. PubMed ID: 36395603
[TBL] [Abstract][Full Text] [Related]
23. Potential 3-chymotrypsin-like cysteine protease cleavage sites in the coronavirus polyproteins pp1a and pp1ab and their possible relevance to COVID-19 vaccine and drug development.
Yan S; Wu G
FASEB J; 2021 May; 35(5):e21573. PubMed ID: 33913206
[TBL] [Abstract][Full Text] [Related]
24. Structure-based inhibitor design and repurposing clinical drugs to target SARS-CoV-2 proteases.
Narayanan A; Toner SA; Jose J
Biochem Soc Trans; 2022 Feb; 50(1):151-165. PubMed ID: 35015073
[TBL] [Abstract][Full Text] [Related]
25. Erythromycin, retapamulin, pyridoxine, folic acid, and ivermectin inhibit cytopathic effect, papain-like protease, and M
Bello SO; Imam MU; Bello MB; Yunusa A; Ahmed Adamu A; Shuaibu A; Igumbor EU; Habib ZG; Popoola MA; Ochu CL; Yahaya Bello A; Deeni YY; Okoye I
Front Cell Infect Microbiol; 2023; 13():1273982. PubMed ID: 38089816
[TBL] [Abstract][Full Text] [Related]
26. Ensitrelvir is effective against SARS-CoV-2 3CL protease mutants circulating globally.
Kawashima S; Matsui Y; Adachi T; Morikawa Y; Inoue K; Takebayashi S; Nobori H; Rokushima M; Tachibana Y; Kato T
Biochem Biophys Res Commun; 2023 Feb; 645():132-136. PubMed ID: 36689809
[TBL] [Abstract][Full Text] [Related]
27. Mechanism and inhibition of the papain-like protease, PLpro, of SARS-CoV-2.
Klemm T; Ebert G; Calleja DJ; Allison CC; Richardson LW; Bernardini JP; Lu BG; Kuchel NW; Grohmann C; Shibata Y; Gan ZY; Cooney JP; Doerflinger M; Au AE; Blackmore TR; van der Heden van Noort GJ; Geurink PP; Ovaa H; Newman J; Riboldi-Tunnicliffe A; Czabotar PE; Mitchell JP; Feltham R; Lechtenberg BC; Lowes KN; Dewson G; Pellegrini M; Lessene G; Komander D
EMBO J; 2020 Sep; 39(18):e106275. PubMed ID: 32845033
[TBL] [Abstract][Full Text] [Related]
28. In Silico Identification of a Potent Arsenic Based Approved Drug Darinaparsin against SARS-CoV-2: Inhibitor of RNA Dependent RNA polymerase (RdRp) and Essential Proteases.
Chowdhury T; Roymahapatra G; Mandal SM
Infect Disord Drug Targets; 2021; 21(4):608-618. PubMed ID: 32718300
[TBL] [Abstract][Full Text] [Related]
29. All-Trans Retinoic Acid Exhibits Antiviral Effect against SARS-CoV-2 by Inhibiting 3CLpro Activity.
Morita T; Miyakawa K; Jeremiah SS; Yamaoka Y; Sada M; Kuniyoshi T; Yang J; Kimura H; Ryo A
Viruses; 2021 Aug; 13(8):. PubMed ID: 34452533
[TBL] [Abstract][Full Text] [Related]
30. Effective inhibition of coronavirus replication by
Xu H; Li J; Song S; Xiao Z; Chen X; Huang B; Sun M; Su G; Zhou D; Wang G; Hao R; Wang N
Front Biosci (Landmark Ed); 2021 Oct; 26(10):789-798. PubMed ID: 34719206
[No Abstract] [Full Text] [Related]
31. Structure-based design of SARS-CoV-2 papain-like protease inhibitors.
Jadhav P; Huang B; Osipiuk J; Zhang X; Tan H; Tesar C; Endres M; Jedrzejczak R; Tan B; Deng X; Joachimiak A; Cai J; Wang J
Eur J Med Chem; 2024 Jan; 264():116011. PubMed ID: 38065031
[TBL] [Abstract][Full Text] [Related]
32. Identification of Cysteine 270 as a Novel Site for Allosteric Modulators of SARS-CoV-2 Papain-Like Protease.
Hu H; Wang Q; Su H; Shao Q; Zhao W; Chen G; Li M; Xu Y
Angew Chem Int Ed Engl; 2022 Dec; 61(52):e202212378. PubMed ID: 36308706
[TBL] [Abstract][Full Text] [Related]
33. Ebselen derivatives inhibit SARS-CoV-2 replication by inhibition of its essential proteins: PL
Zmudzinski M; Rut W; Olech K; Granda J; Giurg M; Burda-Grabowska M; Kaleta R; Zgarbova M; Kasprzyk R; Zhang L; Sun X; Lv Z; Nayak D; Kesik-Brodacka M; Olsen SK; Weber J; Hilgenfeld R; Jemielity J; Drag M
Sci Rep; 2023 Jun; 13(1):9161. PubMed ID: 37280236
[TBL] [Abstract][Full Text] [Related]
34. SARS-CoV-2 3CL
Kuo CJ; Liang PH
FEBS Lett; 2022 May; 596(9):1214-1224. PubMed ID: 35302661
[TBL] [Abstract][Full Text] [Related]
35. Biochemical and biophysical characterization of the main protease, 3-chymotrypsin-like protease (3CLpro) from the novel coronavirus SARS-CoV 2.
Ferreira JC; Rabeh WM
Sci Rep; 2020 Dec; 10(1):22200. PubMed ID: 33335206
[TBL] [Abstract][Full Text] [Related]
36. Glycyrrhizin Effectively Inhibits SARS-CoV-2 Replication by Inhibiting the Viral Main Protease.
van de Sand L; Bormann M; Alt M; Schipper L; Heilingloh CS; Steinmann E; Todt D; Dittmer U; Elsner C; Witzke O; Krawczyk A
Viruses; 2021 Apr; 13(4):. PubMed ID: 33918301
[TBL] [Abstract][Full Text] [Related]
37. Discovery of natural catechol derivatives as covalent SARS-CoV-2 3CL
Wang F; Liu D; Gao D; Yuan J; Zhao J; Yuan S; Cen Y; Lin GQ; Zhao J; Tian P
Int J Biol Macromol; 2024 Apr; 264(Pt 1):130377. PubMed ID: 38395279
[TBL] [Abstract][Full Text] [Related]
38. High-throughput screening of SARS-CoV-2 main and papain-like protease inhibitors.
Zang Y; Su M; Wang Q; Cheng X; Zhang W; Zhao Y; Chen T; Jiang Y; Shen Q; Du J; Tan Q; Wang P; Gao L; Jin Z; Zhang M; Li C; Zhu Y; Feng B; Tang B; Xie H; Wang MW; Zheng M; Pan X; Yang H; Xu Y; Wu B; Zhang L; Rao Z; Yang X; Jiang H; Xiao G; Zhao Q; Li J
Protein Cell; 2023 Jan; 14(1):17-27. PubMed ID: 36726755
[TBL] [Abstract][Full Text] [Related]
39. Structure-Based Design of Potent Peptidomimetic Inhibitors Covalently Targeting SARS-CoV-2 Papain-like Protease.
Wang Q; Chen G; He J; Li J; Xiong M; Su H; Li M; Hu H; Xu Y
Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37239980
[TBL] [Abstract][Full Text] [Related]
40. The in-vitro effect of famotidine on sars-cov-2 proteases and virus replication.
Loffredo M; Lucero H; Chen DY; O'Connell A; Bergqvist S; Munawar A; Bandara A; De Graef S; Weeks SD; Douam F; Saeed M; Munawar AH
Sci Rep; 2021 Mar; 11(1):5433. PubMed ID: 33686143
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]